Lyell Immunopharma Inc (LYEL)
0.95
+0.03
(+3.64%)
USD |
NASDAQ |
Nov 22, 16:00
0.9478
0.00 (0.00%)
After-Hours: 20:00
Lyell Immunopharma Total Assets (Quarterly): 619.22M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 619.22M |
| June 30, 2024 | 654.14M |
| March 31, 2024 | 694.22M |
| December 31, 2023 | 750.03M |
| September 30, 2023 | 794.99M |
| June 30, 2023 | 835.35M |
| March 31, 2023 | 880.45M |
| December 31, 2022 | 937.56M |
| Date | Value |
|---|---|
| September 30, 2022 | 977.27M |
| June 30, 2022 | 1.022B |
| March 31, 2022 | 1.072B |
| December 31, 2021 | 1.127B |
| September 30, 2021 | 1.198B |
| June 30, 2021 | 1.230B |
| March 31, 2021 | 877.19M |
| December 31, 2020 | 908.28M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
619.22M
Minimum
Sep 2024
1.230B
Maximum
Jun 2021
911.13M
Average
894.36M
Median
Total Assets (Quarterly) Benchmarks
| Chimerix Inc | 158.67M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 88.52M |
| Shareholders Equity (Quarterly) | 530.70M |
| Current Ratio | 13.43 |